The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular alterations identified in a phase 1 study of fostamatinib plus paclitaxel in platinum-resistant ovarian cancer.
 
Otavio Al-Alam
No Relationships to Disclose
 
Adam Luo
No Relationships to Disclose
 
Tommy Wu
No Relationships to Disclose
 
Tu-Yung Chang
No Relationships to Disclose
 
Kelly Casella
No Relationships to Disclose
 
Ellen Tully
No Relationships to Disclose
 
Tian-Li Wang
No Relationships to Disclose
 
Eugene Shenderov
Consulting or Advisory Role - Boxer Capital; CapitalOneSecurities; Capvision; FirstThought; Forbion; Gerson Lehrman Group; Guidepoint Global; Health Advances; Insighter; PATHAI
Research Funding - AstraZeneca; Inc Research; MacroGenics
 
Stephanie Gaillard
Consulting or Advisory Role - AstraZeneca; Compugen; Verastem
Research Funding - AstraZeneca (Inst); Beigene (Inst); Blueprint Pharmaceutic (Inst); Compugen (Inst); Genentech/Roche (Inst); Immunogen (Inst); Pharma& (Inst); Tempest Therapeutics (Inst); Verastem (Inst); Volastra Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - United States Patent Nos 10,258,604 & 10,905,659, licensed by Duke University to Sermonix (Inst)